Prague Med. Rep. 2019, 120, 10-17

https://doi.org/10.14712/23362936.2019.6

Is Cardiometabolic Index a Predictive Marker for Renal Cell Cancer Aggressiveness?

Murat Dursun1, Huseyin Besiroglu2, Alper Otunctemur3, Emin Ozbek4

1Department of Urology, Malatya Training and Research Hospital, Malatya, Turkey
2Department of Urology, Catalca Ilyas Cokay State Hospital, Istanbul, Turkey
3Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey
4Department of Urology, Istanbul Cerrahpasa Medical Faculty, Istanbul, Turkey

Received October 17, 2018
Accepted May 2, 2019

Crossref Cited-by Linking

  • Torres-Orozco Anna K., De León Lidia G., Ortiz-Rodríguez Briseidy, Candia-Luján Ramón: Wakabayashi & Daimon cardiometabolic index as an indicator to assess risk in adults. A systematic review. Atención Primaria 2024, 56, 102846. <https://doi.org/10.1016/j.aprim.2023.102846>
  • Fedorko Michal: Metabolic risk factors or renal cell carcinoma. Urolog. pro Praxi 2024, 25, 110. <https://doi.org/10.36290/uro.2024.055>
  • Huang Meng-Jun, Yang Yan-Yi, Chen Can, Luo Rui-Xiang, Wen Chu-Qi, Li Yang, Zeng Ling-Peng, Li Xiang-Yang, Yin Zhuo: Comparison of the predictive value of anthropometric indicators for the risk of benign prostatic hyperplasia in southern China. Asian Journal of Andrology 2023, 25, 265. <https://doi.org/10.4103/aja202249>
Crossref Cited-by Linking logo